HSBC/CALL/AMGEN/280/0.1/15.01.25 | Market Closed - BOERSE MUENCHEN 20:36:11 05/07/2024 BST | ||
| 4.27 EUR | +2.89% |
|
| Current month | -3.83% | ||
| 1 month | -2.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 4.27 | +2.89% |
| 04/07/24 | 4.15 | -0.95% |
| 03/07/24 | 4.19 | -3.68% |
| 02/07/24 | 4.35 | -0.46% |
| 01/07/24 | 4.37 | -1.58% |
Real-time BOERSE MUENCHEN
Last update July 05, 2024 at 08:36 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HG8K74 |
| ISIN | DE000HG8K743 |
| Date issued | 28/02/2023 |
| Strike | 280 $ |
| Maturity | 15/01/2025 (192 Days) |
| Parity | 10 : 1 |
| Emission price | 1.78 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6 € |
|---|---|
| Lowest since issue | 0.69 € |
| Delta | 0.73x |
| Omega | 4.886 |
| Premium | 5.02x |
| Gearing | 6.69x |
| Moneyness | 1.110 |
| Difference Strike | -30.88 $ |
| Difference Strike % | -11.03% |
| Spread | 0.02 € |
| Spread % | 0.47% |
| Theoretical value | 4.290 |
| Implied Volatility | 30.57 % |
| Total Loss Probability | 33.56 % |
| Intrinsic value | 2.849 |
| Present value | 1.441 |
| Break even | 326.50 € |
| Theta | -0.04x |
| Vega | 0.07x |
| Rho | 0.09x |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Warrants
- Warrant
